Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole in Hospitalized COVID-19 Patients
NCT04424901Phase 2Terminated
- Sponsor
- UConn Health
- Start
- May 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dipyridamole in coronavirus disease 2019 (COVID-19), sponsored by UConn Health. Started May 2020; status: terminated.
02
Drugs
dipyridamole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04424901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424901.